References
- Cohen S , YoshiokaT, LucarelliM, HwangLH, LangerR. Controlled delivery systems for proteins based on PLGA microspheres. Pharm. Res.8, 713–720 (1991).
- Park TG , LeeHY, NamYS. A new preparation method for protein loaded poly(D,L-lactic-co-glycolic acid) microspheres and protein release mechanism study. J. Control. Release55, 181–191 (1998).
- Herrmann J , BodmeierR. The effect of particle microstructure on the somatostatin release from poly(lactide) microspheres prepared by a W/O/W solvent evaporation method. J. Control. Release36, 63–71 (1995).
- Lewis AL , IllumL. Formulation strategies for sustained release of proteins. Therapeutic Delivery1(3), 457–479 (2010)
- Wilson B , SamantaMK, MuthuMS, VinothapooshanV. Design and evaluation of chitosan nanoparticles as novel drug carrier for the delivery of rivastigmine to treat Alzheimer‘s disease. Therapeutic Delivery2, 599–609 (2011).
- Zhang JX , ChenD, WangSJ, ZhuKJ. Optimizing double emulsion process to decrease the burst release of protein from biodegradable polymer microspheres. J. Microencapsul.22(4), 413–422 (2005).
- O‘Donnell PB , McginityJW, Preparation of microspheres by the solvent evaporation technique. Adv. Drug Deliv. Rev.28, 25–42 (1997).
- Pitt CG . The controlled parenteral delivery of polypeptides and proteins. Int. J. Pharm.59, 173–196 (1990).
- Jeong KJ , KohaneDS. Surface modification and drug delivery for biointegration. Therapeutic Delivery2(6), 737–752 (2011).
- Ravivarapu HB , LeeH, DeLucaPP. Enhancing initial release of peptide from poly(D,L-lactide-co-glycolide) (PLGA) microspheres by addition of a porosigen and increasing drug load. Pharm. Dev. Technol.5, 287–296 (2000).
- Körber M , BodmeierR. Development of an in situ forming PLGA drug delivery system: I. Characterization of a non-aqueous protein precipitation. Eur J. Pharm. Sci.35, 283–292 (2008).
- Burton KW , ShameemM, ThanooBC, DelucaPP. Extended release peptide delivery systems through the use of PLGA microsphere combinations. J. Biomater. Sci.11, 715–729 (2000).
- Aggarwal A , KaurS, TiwaryAK, GuptaS. Chitosan microspheres prepared by an aqueous process: release of indomethacin. J. Microencapsul.18, 819–823 (2001).
- Chiou SH , WuWT, HuangYY, ChungTW. Effects of the characteristics of chitosan on controlling drug release of chitosan coated PLLA microspheres. J. Microencapsul.18, 613–625 (2001).
- Pazol K , KaplanJR, AbbottD, ApptSE, WilsonME. Practical measurement of total and bioavailable estradiol in female macaques. Clin. Chim. Acta340(1–2), 117–126 (2004).
- Variankaval NE , JacobKI, DinhSM, polymorphism of 17-β estradiol in a transdermal drug delivery system. J. Mater. Sci. Mater. Med.13, 271–280 (2002).
- Mittal G , SahanaDK, BhardwajV, Ravi Kumar MNV. Estradiol loaded PLGA nanoparticles for oral administration: effect of polymer molecular weight and copolymer composition on release behavior in vitro and in vivo. J. Control. Release119, 77–85, (2007).
- Valles S , Dolz-GaitonP, GambiniJet al. Estradiol or genistein prevent Alzheimer‘s disease-associated inflammation correlating with an increase PPAR gamma expression in cultured astrocytes. Brain Res. 1312, 138–144 (2010).
- Weidenauer U , BodmerD, KisselT. Microencapsulation of hydrophilic drug substance using biodegradable polyesters. Part I. Evaluation of different techniques for the encapsulation of pamidronate disodium salt. J. Microencapsul.20, 509–524 (2003).
- Yang YY , ChungTS, BaiXL, ChanWK, Effect of preparation conditions on morphology and release profiles of biodegradable polymeric microspheres containing protein fabricated by double-emulsion method. Chem. Eng. Sci.55, 2223–2236 (2000).
- Mitragotri S , LahannJ. Physical approaches to biomaterial design. Nat. Mater.8, 15–23 (2009).
- Xie J , LimLK, PhuaY, HuaJ, WangCH. Electrohydrodynamic atomization for biodegradable polymeric particle production. J. Colloid Interface Sci.302, 103–112 (2006).
- Wang K , StarkJPW. Deposition of colloidal gold nanoparticles by fully pulsed-voltage-controlled electrohydrodynamic atomisation. J. Nanopart. Res.12, 707–711 (2010).
- Enayati M , AhmadZ, StrideE, EdirisingheM. One-step electrohydrodynamic production of drug-loaded micro- and nanoparticles. J. R. Soc. Interface7, 667–675 (2009).
- Swain BP , PattanayakDK. Simulated body fluid (SBF) adsorption onto a-SiC:H thin films deposited by hot wire chemical vapor deposition (HWCVD). Mater. Lett.62, 3484–3486 (2008).
- Oyane A , KimHM, FuruyaT, KokuboT, MiyazakiT, NakamuraT. Preparation and assessment of revised simulated body fluid. J. Biomed. Mater. Res.65A, 188–195 (2003).
- Iglesias RB , LorenzoCA, ConcheiroA. Controlled release of estradiol solubilized in carbopol/surfactant aggregates. J. Control. Release93, 319–330 (2003).
- Birnbaum DT , KosmalaJD, HenthornDB, Brannon-PeppasL. Controlled release of β-estradiol from PLAGA microparticles: the effect of organic phase solvent on encapsulation and release. J. Control. Release65, 375–387 (2000).
- Hartman RPA , BrunnerDJ, CamelotDMA, MarijnissenJCM, ScarlettB. Jet break-up in electrohydrodynamic atomization in the cone-jet mode. J. Aerosol Sci.31, 65–95 (2000).
- Cloupeau M , Prunet Foch B. Electrostatic spraying of liquids: main functioning modes. J. Electrostat.25, 165–184 (1990).
- Monsky WL , FukumuraD, GohongiTet al. Augmentation of transvascular transport of macromolecules and nanoparticles in tumors using vascular endothelial growth factor. Cancer Res. 59, 4129–4135 (1999).
- Oyewumi MO , MumperRJ. Influence of formulation parameters on gadolinium entrapment and tumor cell uptake using folate-coated nanoparticles. Int. J. Pharm.251(1–2), 85–97 (2003).
- Musante CJ , SchroeterJD, RosatiJA, CrowderTM, HickeyAJ, MartonenTB. Factors affecting the deposition of inhaled porous drug particles. J. Pharm Sci.91, 1590–1600 (2002).
- Edwards DA , HanesJ, CaponettiGet al. Large porous particles for pulmonary drug delivery. Science 276, 1868–1871 (1997).
- Jayasinghe SN , EdirisingheMJ. Effect of viscosity on the size of relics produced by electrostatic atomization. J. Aerosol. Sci.33, 1379–1388 (2002).
- Xu Y , HannaMA. Electrospray encapsulation of water-soluble protein with polylactide effects of formulations on morphology, encapsulation efficiency and release profile of particles. Int. J. Pharm.320, 30–36 (2006).
- Gaumet M , VargasA, GurnyR, DelieF. Nanoparticles for drug delivery: the need for precision in reporting particle size parameters. Eur. J. Pharm. Biopharm.69(1), 1–9 (2008).
- Shive MS , AndersonJM. Biodegradation and biocompatibility of PLA and PLGA microspheres. Adv. Drug Deliv. Rev.28, 5–24 (1997).
- Wu Y , YangW, WangC, HuJ, FuS. Chitosan nanoparticles as a novel delivery system for ammonium glycyrrhizinate. Int. J. Pharm.295(1–2), 235–245 (2005).
- Nam HY , KimDJ, LimHJet al. Reduced burst release from ePTFE grafts: a new coating method for controlled drug release. Bull. Korean Chem. Soc. 29(2), 422–426 (2008).
- Ahmed AR , ElkharrazK, IrfanM, BodmeierR. Reduction in burst release after coating poly(D,L-lactide-co-glycolide) (PLGA) microparticles with a drug-free PLGA layer. Pharm. Dev. Technol.17(1), 66–72 (2012).
- Xiang Z , SarazinP,Favis BD. Controlling burst and final drug release times from porous polylactide devices derived from co-continuous polymer blends. Biomacromolecules10, 2053–2066, (2009).
- Young S , WongM, TabataY, MikosAG. Gelatin as a delivery vehicle for the controlled release of bioactive molecules. J. Control. Release109, 256–274 (2005).
- Curcio M , SpizzirriUG, IemmaFet al. Grafted thermo-responsive gelatin microspheres as delivery systems in triggered drug release. Eur. J. Pharm. Biopharm. 76, 48–55 (2010).
- Patel ZS , YamamotoM, UedaH, TabataY, MikosAG. Biodegradable gelatin microparticles as delivery systems for the controlled release of bone morphogenetic protein-2. Acta Biomaterialia4, 1126–1138 (2008).